415 related articles for article (PubMed ID: 24507546)
41. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Mehndiratta MM; Hughes RA
Cochrane Database Syst Rev; 2002; (1):CD002062. PubMed ID: 11869620
[TBL] [Abstract][Full Text] [Related]
42. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
43. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.
Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N
Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227
[TBL] [Abstract][Full Text] [Related]
44. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Mehndiratta MM; Hughes RA
Cochrane Database Syst Rev; 2001; (3):CD002062. PubMed ID: 11687011
[TBL] [Abstract][Full Text] [Related]
45. Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.
Press R; Hiew FL; Rajabally YA
Acta Neurol Scand; 2016 Apr; 133(4):228-38. PubMed ID: 26437234
[TBL] [Abstract][Full Text] [Related]
46. The treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Kissel JT
Semin Neurol; 2003 Jun; 23(2):169-80. PubMed ID: 12894382
[TBL] [Abstract][Full Text] [Related]
47. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
Hughes RA
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
[TBL] [Abstract][Full Text] [Related]
48. Management of chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA
Drugs; 2003; 63(3):275-87. PubMed ID: 12534332
[TBL] [Abstract][Full Text] [Related]
49. Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; van Doorn PA
Drugs; 2009 May; 69(8):987-1001. PubMed ID: 19496628
[TBL] [Abstract][Full Text] [Related]
50. [Chronic inflammatory demyelinating polyneuropathy: Diagnosis and therapeutic update].
Franques J
Rev Med Interne; 2019 Dec; 40(12):808-815. PubMed ID: 31677862
[TBL] [Abstract][Full Text] [Related]
51. A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy.
Léger JM
Expert Opin Pharmacother; 2005 Apr; 6(4):569-82. PubMed ID: 15934883
[TBL] [Abstract][Full Text] [Related]
52. Relapse with Dysphagia in a Case of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Teramoto H; Morita A; Hara M; Ninomiya S; Shigihara S; Kusunoki S; Kamei S
Intern Med; 2015; 54(14):1791-3. PubMed ID: 26179538
[TBL] [Abstract][Full Text] [Related]
53. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Bunschoten C; Jacobs BC; Van den Bergh PYK; Cornblath DR; van Doorn PA
Lancet Neurol; 2019 Aug; 18(8):784-794. PubMed ID: 31076244
[TBL] [Abstract][Full Text] [Related]
54. Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.
Vallat JM; Mathis S; Ghorab K; Milor MA; Richard L; Magy L
Eur Neurol; 2015; 73(5-6):294-302. PubMed ID: 25925430
[TBL] [Abstract][Full Text] [Related]
55. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop.
Adrichem ME; Eftimov F; van Schaik IN
J Peripher Nerv Syst; 2016 Sep; 21(3):121-7. PubMed ID: 27241239
[TBL] [Abstract][Full Text] [Related]
56. [Treatment of chronic inflammatory demyelinating polyradiculoneuropathy(CIDP)--a review].
Mezaki T; Kaji R
No To Shinkei; 2000 Dec; 52(12):1063-9. PubMed ID: 11193538
[TBL] [Abstract][Full Text] [Related]
57. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Nobile-Orazio E; Cocito D; Jann S; Uncini A; Beghi E; Messina P; Antonini G; Fazio R; Gallia F; Schenone A; Francia A; Pareyson D; Santoro L; Tamburin S; Macchia R; Cavaletti G; Giannini F; Sabatelli M;
Lancet Neurol; 2012 Jun; 11(6):493-502. PubMed ID: 22578914
[TBL] [Abstract][Full Text] [Related]
58. Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature.
Benedetti L; Briani C; Franciotta D; Fazio R; Paolasso I; Comi C; Luigetti M; Sabatelli M; Giannini F; Mancardi GL; Schenone A; Nobile-Orazio E; Cocito D
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):306-8. PubMed ID: 20639381
[TBL] [Abstract][Full Text] [Related]
59. Atypical chronic inflammatory demyelinating polyradiculoneuropathy with ophthalmoplegia and anti-sulfatide IgM positivity.
Chen L; Zhang Y; Qin N; Han R; Li Y
J Int Med Res; 2023 Oct; 51(10):3000605231193575. PubMed ID: 37812511
[TBL] [Abstract][Full Text] [Related]
60. Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy.
Marsh EA; Hirst CL; Llewelyn JG; Cossburn MD; Reilly MM; Krishnan A; Doran M; Ryan AM; Coles AJ; Jones JL; Robertson NP
J Neurol; 2010 Jun; 257(6):913-9. PubMed ID: 20049473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
